We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
Paliperidone for a patient with delayed-onset performance and memory dysfunction and neuropsychiatric symptoms associated with carbon monoxide intoxication
Published online by Cambridge University Press:
24 June 2014
Department of Emergency Medicine, College of Medicine, Cheonan, South Korea
Myung-Ho Lim*
Affiliation:
Department of Psychiatry, Environmental Health Center, College of Medicine, Cheonan, South Korea
Ho-Jang Kwon
Affiliation:
Department of Preventive Medicine, Environmental Health Center, College of Medicine, Cheonan, South Korea
Dong-Soo Yoo
Affiliation:
Department of Radiology, College of Medicine, Cheonan, South Korea
Chang-Min Lee
Affiliation:
Department of Neurology, College of Medicine, Cheonan, South Korea
*
Myung-Ho Lim, MD Department of Psychiatry, Environmental Center, College of Medicine, Dankook University, Manghyang Rho 359, Cheonan 330714, South Korea. Tel: +82 10 26401498; Fax: +82 42 5613007; E-mail: paperose@dku.edu
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
3.Choi, IS.Carbon monoxide poisoning: systemic manifestations and complications.J Korean Med Sci2001;16:253–261.CrossRefGoogle ScholarPubMed
4
4.Hu, MC, Shiah, IS, Yeh, CB, Chen, HK, Chen, CK.Ziprasidone in the treatment of delayed carbon monoxide.Encephalopathy2006;30:755–757.Google ScholarPubMed
5
5.Pae, CU, Kim, TS, Lee, C, Paik, IH.Effect of aripiprazole for a patient with psychotic symptoms and parkinsonism associated with delayed-sequelae of carbon monoxide intoxication.J Neuropsychiat Clin Neurosci2006;18:130–131.CrossRefGoogle ScholarPubMed
6
6.Leysen, JE, Janssen, PM, Megens, AA, Schotte, A.Risperidone: a novel antipsychotic with balanced serotonin–dopamine antagonism, receptor occupancy profile, and pharmacologic activity.J Clin Psychiat1994;55(Suppl): 5–12.Google Scholar
7
7.Richelson, E, Souder, T.Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds.Life Sci2000;68:29–39.CrossRefGoogle ScholarPubMed
8
8.Nasrallah, HA.Atypical antipsychotic-induced metabolic side effects: insights from receptor binding profiles.Mol Psychiat2008;13:27–35.Google Scholar
9
9.Fowler, JA, Bettinger, TL, Argo, TR.Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.Clin Ther2008;30:231–248.Google Scholar
10
10.Yulug, B, Yildiz, A, Guzel, O, Kilic, E, Schabitz, WR, Kilic, E.Risperidone attenuates brain damage after focal cerebral ischemia in vivo.Brain Res Bull2006;69:656–659.Google Scholar
11
11.Correll, CU, Leucht, S, Kane, JM.Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of l-year studies.Am J Psychiat2004;161:414–425.Google Scholar
12
12.Tandon, R, Jibson, MD.Extrapyramidal side effects of antipsychotic treatment: scope of problem and impact on outcome.Ann Clin Psychiat2002;14:123–129.CrossRefGoogle ScholarPubMed
13
13.Woodward, ND, Purdon, SE, Meltzer, HY, Zald, DH.A metaanalysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effects.Schizophr Res2007;89:211–224.Google Scholar
14
14.Keefe, RS, Bilder, RM, Davis, SM et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.Arch Gen Psychiat2007;64:633–647.CrossRefGoogle ScholarPubMed
15
15.Grootens, KP, Van Veelen, NM, Peuskens, J et al. Ziprasidone vs olanzapine in recent-onset schizophrenia and schizoaffective disorder: results of an 8-week double-blind randomized controlled trial.Schizophr Bull2011;37:352–361.CrossRefGoogle ScholarPubMed
16
16.Van Veelen, NM, Grootens, KP, Peuskens, J et al. Short term neurocognitive effects of treatment with ziprasidone and olanzapine in recent onset schizophrenia.Schizophr Res2010;120:191–198.Google Scholar
17
17.Nussbaum, A, Stroup, TS.Paliperidone for schizophrenia.Cochrane Database Syst Rev2008;16:CD006369.Google Scholar